No matter how Codexis (Nasdaq: CDXS) shares jumped in the late session on Friday

SFT Stock

A leading protein engineering firm, Codexis (Nasdaq: CDXS), stock in postmarket trade has grown 14.17% to $7.001. There does not seem to be any business news that today prompted the price of Codexis share to surge, and investors would want to take this as a signal for warning. However, on December 02, 2020, the pricing […]

Is that why Aerpio Pharmaceuticals (Nasdaq: ARPO) stock plunged in the AH session?

MTTR

Aerpio Pharmaceuticals, (Nasdaq: ARPO), the stock dipped -40.89% to $1.33 in the After-market session, as Razuprotafib met its primary efficacy endpoint at 28 days in Aerpio’s double-blind Phase 2 trial in patients with elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. Compared to the monotherapy group, razuprotafib did not show any statistically significant […]